Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Colonic LRRK2 expression is increased in Crohn's disease but not in Parkinson's disease and idiopathic RBD.

van der Haas J, Mantel M, Sellier-Montaigne L, de Guilhem de Lataillade A, Durand T, Oullier T, Le Berre C, Letournel F, Rolli-Derkinderen M, Leclair-Visonneau L, Derkinderen P.

Acta Neuropathol · 2026-09-19

DOI: 10.1007/s00401-026-03087-2PMID: 42762331

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Clinical and genetic findings in Parkinson's disease in a Turkish cohort: a retrospective exome sequencing study.

Canbek S, Gulseven MF, Mert G, Senol MG.

Neurogenetics · 2026-09-19

DOI: 10.1007/s10048-026-00943-xPMID: 42762359

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

GBA1 in Parkinson's disease: past, present and future.

Gan-Or Z.

Brain · 2026-09-18

DOI: 10.1093/brain/awag322PMID: 42758574

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Imaging nanoscopic co-assemblies of α-synuclein and Tau in human samples.

Zhang YP, Wallis A, Bertroli CO, Zhang C, Burke M, Layburn F, Lobanova E, Furlepa M, Kedia S, Cui Y, Suresh P, Yang WS, Quaegebeur A, Bartels T, Williams-Gray CH, Klenerman D.

Nat Commun · 2026-09-18

DOI: 10.1038/s41467-026-77728-1PMID: 42897149

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Genome-wide cross-trait analysis to compare genetic architecture between Parkinson's disease and kidney-related traits.

Chang L, Gawhary S, Maameri L, Belbellaj W, Lona-Durazo F, Gagliano Taliun SA.

Nat Commun · 2026-09-18

DOI: 10.1038/s41467-026-77920-3PMID: 42901928

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Cellular prion protein levels modulate nigrostriatal vulnerability to α-synuclein oligomers in Parkinson's disease.

de Souza Júnyor F, Leser FS, de Souza Albuquerque S, de Barros-Telles R, Heimfarth L, da Silva Andrade B, Furtado CM, da Silva LF, Dos Santos FCP, de Oliveira ALSR, Ferreira ST, Braga C, da Fonseca CG, Neves GA, Romão L, Lima FRS.

Front Neurosci · 2026-09-17

DOI: 10.3389/fnins.2026.1913279PMID: 42824715

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

TLR2 Regulates α-Synuclein Phosphorylation and Release in an Enteroendocrine Cell Model.

Hu J, Elsaid S, Wu X, Ambye N, Tee SS.

Mol Neurobiol · 2026-09-16

DOI: 10.1007/s12035-026-06206-yPMID: 42747668

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Disrupted TFEB/GDNF-cAMP/ATP Coupling Underlies Astrocytic Dysfunction and Depression in LRRK2 G2019S Parkinson's Mice.

Yao L, Hatami M, Koc S, Jiang Q, Skutella T, Zhang Y.

Adv Sci (Weinh) · 2026-09-16

DOI: 10.1002/advs.202522066PMID: 42750142

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Disease Course Map progression markers transfer from isolated REM sleep behavior disorder to non-RBD prodromal alpha-synucleinopathy: a PPMI study of 1,499 participants.

Fontana JC, Guimarães RL, de Faria AS, Braz KM, de Sá Pereira JF, Corrêa EM.

Parkinsonism Relat Disord · 2026-09-15

DOI: 10.1016/j.parkreldis.2026.108985PMID: 42743773

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Association between cerebrospinal fluid LRRK2 and incident orthostatic hypotension differs by genetic background in Parkinson's disease.

Kazemi E.

Acta Neurol Belg · 2026-09-14

DOI: 10.1007/s13760-026-03194-7PMID: 42734894

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Correction: Ti et al. Blood-Based α-Synuclein Biomarkers in Parkinson's Disease: Molecular Diversity, Analytical Advances and Clinical Translation. <i>Int. J. Mol. Sci.</i> 2026, <i>27</i>, 6254.

Ti K, Zhao Y, Tan EK, Ma D.

Int J Mol Sci · 2026-09-14

DOI: 10.3390/ijms27188177PMID: 42794862

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Genetics of α-Synuclein: The Prime Pathological Player of Parkinson's Disease.

Sarhadi TR, Joshi N, Raveendran A, Panse JS, Nagotu S.

Neurotox Res · 2026-09-12

DOI: 10.1007/s12640-026-00827-wPMID: 42730873

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

9.897 makale bulundu

Colonic LRRK2 expression is increased in Crohn's disease but not in Parkinson's disease and idiopathic RBD.

Clinical and genetic findings in Parkinson's disease in a Turkish cohort: a retrospective exome sequencing study.

GBA1 in Parkinson's disease: past, present and future.

Imaging nanoscopic co-assemblies of α-synuclein and Tau in human samples.

Genome-wide cross-trait analysis to compare genetic architecture between Parkinson's disease and kidney-related traits.

Cellular prion protein levels modulate nigrostriatal vulnerability to α-synuclein oligomers in Parkinson's disease.

TLR2 Regulates α-Synuclein Phosphorylation and Release in an Enteroendocrine Cell Model.

Disrupted TFEB/GDNF-cAMP/ATP Coupling Underlies Astrocytic Dysfunction and Depression in LRRK2 G2019S Parkinson's Mice.

Disease Course Map progression markers transfer from isolated REM sleep behavior disorder to non-RBD prodromal alpha-synucleinopathy: a PPMI study of 1,499 participants.

Association between cerebrospinal fluid LRRK2 and incident orthostatic hypotension differs by genetic background in Parkinson's disease.

Correction: Ti et al. Blood-Based α-Synuclein Biomarkers in Parkinson's Disease: Molecular Diversity, Analytical Advances and Clinical Translation. <i>Int. J. Mol. Sci.</i> 2026, <i>27</i>, 6254.

Genetics of α-Synuclein: The Prime Pathological Player of Parkinson's Disease.

Filtreler